Optimizing therapy in pediatric acute lymphoblastic leukemia (ALL ): the crucial role of monitoring 6-mercaptopurine metabolites
Revista Medicina Universitaria · 10.04.2026 · 28 (2)
DOI: 10.24875/rmu.25000043 ↗Kurz gefasst
Fachartikel in der Zeitschrift Revista Medicina Universitaria, online erschienen am 10.04.2026. Verfasst von Ana L. Valdez-Arellanes und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Valdez-Arellanes, A. L., Garza-Ocañas, L., & Badillo-Castañeda, C. T. (2026). Optimizing therapy in pediatric acute lymphoblastic leukemia (ALL ): the crucial role of monitoring 6-mercaptopurine metabolites. Revista Medicina Universitaria, 28(2). https://doi.org/10.24875/rmu.25000043
Vancouver
Valdez-Arellanes AL, Garza-Ocañas L, Badillo-Castañeda CT. Optimizing therapy in pediatric acute lymphoblastic leukemia (ALL ): the crucial role of monitoring 6-mercaptopurine metabolites. Revista Medicina Universitaria. 2026;28(2). doi:10.24875/rmu.25000043
BibTeX
@article{ValdezArellanes2026,
author = {Valdez-Arellanes, Ana L. and Garza-Ocañas, Lourdes and Badillo-Castañeda, Christian T.},
title = {Optimizing therapy in pediatric acute lymphoblastic leukemia (ALL ): the crucial role of monitoring 6-mercaptopurine metabolites},
journal = {Revista Medicina Universitaria},
year = {2026},
volume = {28},
number = {2},
doi = {10.24875/rmu.25000043}
}
EUVIMED